A pliable ERα cistrome evades therapy

Xiaoli S Wu^{1

2}, Christopher R Vakoc³

Affiliations

Comment

Xiaoli S Wu et al. Nat Cell Biol. 2020 Jun.

. 2020 Jun;22(6):619-620.

doi: 10.1038/s41556-020-0528-6.

Xiaoli S Wu^{1

2}, Christopher R Vakoc³

No abstract available

Comment on

Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance.
Bi M, Zhang Z, Jiang YZ, Xue P, Wang H, Lai Z, Fu X, De Angelis C, Gong Y, Gao Z, Ruan J, Jin VX, Marangoni E, Montaudon E, Glass CK, Li W, Huang TH, Shao ZM, Schiff R, Chen L, Liu Z. Bi M, et al. Nat Cell Biol. 2020 Jun;22(6):701-715. doi: 10.1038/s41556-020-0514-z. Epub 2020 May 18. Nat Cell Biol. 2020. PMID: 32424275 Free PMC article.

1. Darnell, J. E. Jr. Nat. Rev. Cancer 2, 740–749 (2002). - DOI
1. Bhagwat, A. S. & Vakoc, C. R. Trends Cancer 1, 53–65 (2015). - DOI
1. Hanker, A. B., Sudhan, D. R. & Arteaga, C. L. Cancer Cell 37, 496–513 (2020). - DOI
1. Bi, M. et al. Nat. Cell Biol. https://doi.org/10.1038/s41556-020-0514-z (2020).
1. Ross-Innes, C. S. et al. Nature 481, 389–393 (2012). - DOI